Cancer can be a wake-up call — often to the things we haven’t fully appreciated in life. For Jason Trennert , one of those things was compliance meetings. Like many on Wall Street, the 57-year-old head of Strategas Research Partners — known for his prophetic, contrarian bets on the success of President Trump and many of his controversial policies — had always dreaded long, tedious sessions with lawyers combing through regulatory paperwork. These days, Trennert says the prospect of those mind-